Wait a moment
Biopure Submits IND Application For Proposed Clinical Trial In Patients With Acute Myeloid Leukemia
FDA delays study of blood substitute from Biopure
Biopure Corporation Release: Requested Operations Trial on FDA Hold
Biopure Corporation Receives Extension of Time to Regain Listing...
Nasdaq gives Biopure a break from enforcing trading compliance
Positive Seasonal Pattern Stocks on Monday the 5th of January 2009
Nasdaq gives Biopure a break from enforcing trading compliance
FDA blocks Naval trial of Hemopure
FDA Calendar: Allergan's New Rx for Eyelashes
Skin young and acne: cleansing and makeup products with suitable 